Literature DB >> 1882200

Antimicrobial therapy of septicemic patients in intensive care units before and after blood culture reporting.

E Rintala1, V Kairisto, E Eerola, J Nikoskelainen, O P Lehtonen.   

Abstract

68 cases of positive blood cultures from 54 intensive care unit (ICU) patients were analyzed retrospectively. The empiric antimicrobial therapy was correct in 65% of the cases as judged by the species and sensitivity of the blood culture isolate. After initial Gram-staining results were known, coverage increased to 77%. After the final blood culture results the coverage was still only 81%. The bacteremia-related mortality was 13%. Although there was no significant difference between the occurrence of bacteremia-related and non-bacteremia-related deaths either in patients with correct or non-optimal empiric treatment, this study emphasizes the need for better utilization of culture reporting. A considerable part of the final blood culture results went unnoticed by the ICU physicians which stresses the importance of good communication between the laboratory and wards.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882200     DOI: 10.3109/00365549109024321

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  First notification of positive blood cultures and the high accuracy of the gram stain report.

Authors:  Mette Søgaard; Mette Nørgaard; Henrik C Schønheyder
Journal:  J Clin Microbiol       Date:  2007-02-14       Impact factor: 5.948

2.  Application of a 16S rRNA PCR-high-resolution melt analysis assay for rapid detection of Salmonella Bacteremia.

Authors:  Kevin Jeng; Samuel Yang; Helen Won; Charlotte A Gaydos; Yu-Hsiang Hsieh; Alex Kecojevic; Karen C Carroll; Justin Hardick; Richard E Rothman
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions.

Authors:  Moonsuk Kim; Kyoung-Ho Song; Chung-Jong Kim; Minkyo Song; Pyoeng Gyun Choe; Wan Beom Park; Ji Hwan Bang; Hee Hwang; Eu Suk Kim; Sang-Won Park; Nam Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.